Literature DB >> 26666817

Silencing stem cell factor attenuates stemness and inhibits migration of cancer stem cells derived from Lewis lung carcinoma cells.

Li Wang1, JianTao Wang1, Zhixi Li1, YanYang Liu1, Ming Jiang1, Yan Li1, Dan Cao1, Maoyuan Zhao1, Feng Wang1, Feng Luo2.   

Abstract

Stem cell factor (SCF) plays an important role in tumor growth and metastasis. However, the function of SCF in regulating stemness and migration of cancer stem cells (CSCs) remains largely undefined. Here, we report that non-adhesive culture system can enrich and expand CSCs derived from Lewis lung carcinoma (LLC) cells and that the expression level of SCF in CSCs was higher than those in LLC cells. Silencing SCF via short hairpin (sh) RNA lentivirus transduction attenuated sphere formation and inhibited expressions of stemness genes, ALDH1, Sox2, and Oct4 of CSCs in vitro and in vivo. Moreover, SCF-silenced CSCs inhibited the migration and epithelial-mesenchymal transition, with decreased expression of N-cadherin, Vimentin, and increased expression of E-cadherin in vitro and in vivo. Finally, SCF-short hairpin RNA (shRNA) lentivirus transduction suppressed tumorigenicity of CSCs. Taken together, our findings unraveled an important role of SCF in CSCs derived from LLC cells. SCF might serve as a novel target for lung cancer therapy.

Entities:  

Keywords:  Cancer stem cell; Epithelial-mesenchymal transformation; Lewis lung carcinoma; Stem cell factor

Mesh:

Substances:

Year:  2015        PMID: 26666817     DOI: 10.1007/s13277-015-4577-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  51 in total

1.  Increased differentiation capacity of bone marrow-derived mesenchymal stem cells in aquaporin-5 deficiency.

Authors:  Fei Yi; Muhammad Khan; Hongwen Gao; Feng Hao; Meiyan Sun; Lili Zhong; Changzheng Lu; Xuechao Feng; Tonghui Ma
Journal:  Stem Cells Dev       Date:  2012-04-20       Impact factor: 3.272

2.  Primary structure and functional expression of rat and human stem cell factor DNAs.

Authors:  F H Martin; S V Suggs; K E Langley; H S Lu; J Ting; K H Okino; C F Morris; I K McNiece; F W Jacobsen; E A Mendiaz
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

3.  ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.

Authors:  Zheng-Yuan Xie; Ke Lv; Ying Xiong; Wu-Hua Guo
Journal:  Oncol Res Treat       Date:  2014-10-17       Impact factor: 2.825

4.  Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties.

Authors:  Linlin Zhang; Min Jiao; Lei Li; Dapeng Wu; Kaijie Wu; Xiang Li; Guodong Zhu; Qiang Dang; Xinyang Wang; Jer-Tsong Hsieh; Dalin He
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-12       Impact factor: 4.553

5.  Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor.

Authors:  M C Heinrich; D J Griffith; B J Druker; C L Wait; K A Ott; A J Zigler
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

Review 6.  Review: melanocyte migration and survival controlled by SCF/c-kit expression.

Authors:  H Yoshida; T Kunisada; T Grimm; E K Nishimura; E Nishioka; S I Nishikawa
Journal:  J Investig Dermatol Symp Proc       Date:  2001-11

Review 7.  Stem cell factor receptor/c-Kit: from basic science to clinical implications.

Authors:  Johan Lennartsson; Lars Rönnstrand
Journal:  Physiol Rev       Date:  2012-10       Impact factor: 37.312

8.  Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.

Authors:  Caiyu Lin; Li Wang; Hong Wang; Liuqi Yang; Huijie Guo; Xiujie Wang
Journal:  J Cell Biochem       Date:  2013-09       Impact factor: 4.429

9.  Identification and characterization of ovarian cancer-initiating cells from primary human tumors.

Authors:  Shu Zhang; Curt Balch; Michael W Chan; Hung-Cheng Lai; Daniela Matei; Jeanne M Schilder; Pearlly S Yan; Tim H-M Huang; Kenneth P Nephew
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

10.  Nonadhesive culture system as a model of rapid sphere formation with cancer stem cell properties.

Authors:  Su-Feng Chen; Yun-Ching Chang; Shin Nieh; Chia-Lin Liu; Chin-Yuh Yang; Yaoh-Shiang Lin
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

View more
  6 in total

Review 1.  Clinical and Biological Implications of Cancer Stem Cells in Hepatocellular Carcinoma.

Authors:  Hiroyuki Tsuchiya; Goshi Shiota
Journal:  Yonago Acta Med       Date:  2021-01-06       Impact factor: 1.641

Review 2.  RNA interference-based therapy and its delivery systems.

Authors:  Xiuhui Chen; Lingegowda S Mangala; Cristian Rodriguez-Aguayo; Xianchao Kong; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

3.  LncRNA HAND2-AS1 represses cervical cancer progression by interaction with transcription factor E2F4 at the promoter of C16orf74.

Authors:  Junling Gong; Haiying Fan; Jing Deng; Qiumei Zhang
Journal:  J Cell Mol Med       Date:  2020-04-21       Impact factor: 5.310

4.  A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer.

Authors:  Elena Laura Mazzoldi; Simona Pavan; Giorgia Pilotto; Kevin Leone; Anna Pagotto; Simona Frezzini; Maria Ornella Nicoletto; Alberto Amadori; Anna Pastò
Journal:  Cell Death Dis       Date:  2019-05-28       Impact factor: 8.469

5.  Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients.

Authors:  Jun Liu; Zheng Chen; Wenli Li
Journal:  J Oncol       Date:  2021-03-17       Impact factor: 4.375

Review 6.  The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment.

Authors:  Haoyue Hu; Yue Chen; Songtao Tan; Silin Wu; Yan Huang; Shengya Fu; Feng Luo; Jun He
Journal:  Front Immunol       Date:  2022-02-23       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.